brightsun
2021-09-21
Nice
After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":860268305,"tweetId":"860268305","gmtCreate":1632183149707,"gmtModify":1632802283665,"author":{"id":3570689780555896,"idStr":"3570689780555896","authorId":3570689780555896,"authorIdStr":"3570689780555896","name":"brightsun","avatar":"https://static.tigerbbs.com/50f01966a534f410b4455882da98d0f9","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice </p></body></html>","htmlText":"<html><head></head><body><p>Nice </p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/860268305","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://www.laohu8.com/m/news/2169533684?lang=&edition=full","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SDC":"SmileDirectClub, Inc.","VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":34,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/860268305"}
精彩评论